AER 1541201 is a spontaneous case, received from a physician via AEMPS, health authority, (Spain, ES-
AGEMED-008349344) and concerns a 71 year old male patient who died due to progressive multifocal 
leukoencephalopathy while being treated with rituximab (Mabthera).
No medical history, concurrent illness, concomitant medications or past drugs were reported.
On 05/Oct/2011, the patient started intravenous rituximab 750 mg solution for injection 1 per 1 cyclical for unknown 
indication. On (b) (6)  he developed progressive multifocal leukoencephalopathy with permanent disability 
leading to hospitalization. Later, he died due to progressive multifocal leukoencephalopathy. It was not reported 
whether autopsy was performed or not.
At the time of death, therapy ongoing status of rituximab was unknown.
Print Time: 07-JUN-2016 03:01 PM If a field is blank, there is no data for that field Page 41 of 549
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
The physician did not provide causal relationship of progressive multifocal leukoencephalopathy with rituximab.
No further information was provided.